|285.08||+0.6700||+0.24%||Vol 959.69K||1Y Perf -2.94%|
|Oct 4th, 2023 16:00 DELAYED|
|- -||- -%|
|Target Price||344.00||Analyst Rating||Moderate Buy 1.97|
|Potential %||20.67||Finscreener Ranking||★★★ 48.71|
|Insiders Trans % 3/6/12 mo.||-100/-100/-89||Value Ranking||★★★ 51.21|
|Insiders Value % 3/6/12 mo.||-100/-100/-99||Growth Ranking||★★★+ 55.61|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-99||Income Ranking||★★★ 46.41|
|Price Range Ratio 52W %||44.75||Earnings Rating||Sell|
|Market Cap||84.38B||Earnings Date||2nd Nov 2023|
Today's Price Range
5 Year PE Ratio Range
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||2nd Nov 2023|
|Estimated EPS Next Report||6.66|
|EPS Growth Next 5 Years %||11.20|
|Avg. Weekly Volume||1.08M|
|Avg. Monthly Volume||1.04M|
|Avg. Quarterly Volume||1.27M|
Cigna Corporation (NYSE: CI) stock closed at 284.41 per share at the end of the most recent trading day (a -1.09% change compared to the prior day closing price) with a volume of 971.76K shares and market capitalization of 84.38B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Plans industry, Healthcare sector and employs 73700 people. Cigna Corporation CEO is David M. Cordani.
The one-year performance of Cigna Corporation stock is -2.94%, while year-to-date (YTD) performance is -14.16%. CI stock has a five-year performance of 33.76%. Its 52-week range is between 240.5 and 340.11, which gives CI stock a 52-week price range ratio of 44.75%
Cigna Corporation currently has a PE ratio of 14.40, a price-to-book (PB) ratio of 2.05, a price-to-sale (PS) ratio of 0.69, a price to cashflow ratio of 8.90, a PEG ratio of 1.29, a ROA of 4.81%, a ROC of -% and a ROE of 15.53%. The company’s profit margin is 4.13%, its EBITDA margin is -%, and its revenue ttm is $134.27 Billion , which makes it $439.17 revenue per share.
Of the last four earnings reports from Cigna Corporation, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $6.66 for the next earnings report. Cigna Corporation’s next earnings report date is 02nd Nov 2023.
The consensus rating of Wall Street analysts for Cigna Corporation is Moderate Buy (1.97), with a target price of $344, which is +20.67% compared to the current price. The earnings rating for Cigna Corporation stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Cigna Corporation has a dividend yield of 1.48% with a dividend per share of $4.48 and a payout ratio of 4.00%.
Cigna Corporation has a Neutral technical analysis rating based on Technical Indicators (ADX : 12.99, ATR14 : 5.09, CCI20 : -21.27, Chaikin Money Flow : -0.08, MACD : 1.20, Money Flow Index : 45.91, ROC : 0.42, RSI : 47.90, STOCH (14,3) : 20.72, STOCH RSI : 0.00, UO : 43.67, Williams %R : -79.28), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Cigna Corporation in the last 12-months were: Cordani David (Sold 20 148 shares of value $5 924 721 ), Cynthia Ryan (Option Excercise at a value of $521 936), Cynthia Ryan (Sold 3 812 shares of value $1 222 932 ), David M. Cordani (Sold 20 148 shares of value $5 924 721 ), Donna F. Zarcone (Sold 2 088 shares of value $567 247 ), Elder Granger (Sold 322 shares of value $87 478 ), Eric Palmer (Sold 4 000 shares of value $1 200 004 ), Everett Neville (Sold 5 208 shares of value $1 462 400 ), Granger Elder (Sold 322 shares of value $87 478 ), Jason D. Sadler (Option Excercise at a value of $8 107 870), Jason D. Sadler (Sold 33 334 shares of value $11 129 526 ), Jones Nicole (Sold 6 067 shares of value $1 780 707 ), Michael Triplett (Sold 1 731 shares of value $470 261 ), Neville Everett (Option Exercise at a value of $3 024 778), Neville Everett (Sold 18 365 shares of value $5 346 478 ), Nicole S. Jones (Sold 5 404 shares of value $1 589 100 ), Paul A. Sanford (Sold 373 shares of value $111 900 ), Ryan Cynthia (Option Excercise at a value of $513 936), Ryan Cynthia (Sold 4 571 shares of value $1 299 535 ), Sanford Paul A (Sold 1 507 shares of value $444 881 ), Triplett Michael (Sold 1 731 shares of value $470 261 )
Tue, 08 Aug 2023 09:20 GMT Analysts Offer Insights on Healthcare Companies: Inogen (INGN), Cigna (CI) and Stryker (SYK)- TipRanks. All rights reserved.
Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
General partner of Finscreener is SLOVAKODATA, a.s.
This could take some time, please wait.